Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of upadacitinib in adults with active ankylosing spondylitis has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Ankylosing Spondylitis (AS) | Phase 2 | Status: COMPLETED | Results posted: 2021-06-01